{"id":"https://openalex.org/W2848747403","doi":"https://doi.org/10.1097/cmr.0000000000000472","title":"Severe skin toxicity with organ damage under the combination of targeted therapy following immunotherapy in metastatic melanoma","display_name":"Severe skin toxicity with organ damage under the combination of targeted therapy following immunotherapy in metastatic melanoma","publication_year":2018,"publication_date":"2018-07-07","ids":{"openalex":"https://openalex.org/W2848747403","doi":"https://doi.org/10.1097/cmr.0000000000000472","mag":"2848747403","pmid":"https://pubmed.ncbi.nlm.nih.gov/29985833"},"language":"en","primary_location":{"id":"doi:10.1097/cmr.0000000000000472","doi":"https://doi.org/10.1097/cmr.0000000000000472","is_oa":false,"landing_page_url":"https://doi.org/10.1097/cmr.0000000000000472","pdf_url":null,"source":{"id":"https://openalex.org/S3207524","display_name":"Melanoma Research","issn_l":"0960-8931","issn":["0960-8931","1473-5636"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Melanoma Research","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5000000649","display_name":"Marie Lamiaux","orcid":"https://orcid.org/0000-0002-7696-3511","observed_orcids":["https://orcid.org/0000-0002-7696-3511"]},"institutions":[{"id":"https://openalex.org/I3018718406","display_name":"Centre Hospitalier Universitaire de Lille","ror":"https://ror.org/02ppyfa04","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3018718406"]},{"id":"https://openalex.org/I4210155195","display_name":"H\u00f4pital Claude Huriez","ror":"https://ror.org/05cpv3t46","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3018718406","https://openalex.org/I4210155195"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Marie Lamiaux","raw_affiliation_strings":["Department of Dermatology, Claude Huriez Hospital, CHRU Lille"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology, Claude Huriez Hospital, CHRU Lille","institution_ids":["https://openalex.org/I3018718406","https://openalex.org/I4210155195"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039088635","display_name":"C. Scalbert","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2279609970","display_name":"Universit\u00e9 de Lille","ror":"https://ror.org/02kzqn938","country_code":"FR","type":"education","lineage":["https://openalex.org/I2279609970"]},{"id":"https://openalex.org/I3018718406","display_name":"Centre Hospitalier Universitaire de Lille","ror":"https://ror.org/02ppyfa04","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3018718406"]},{"id":"https://openalex.org/I4210155195","display_name":"H\u00f4pital Claude Huriez","ror":"https://ror.org/05cpv3t46","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3018718406","https://openalex.org/I4210155195"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Camille Scalbert","raw_affiliation_strings":["Department of Dermatology, Claude Huriez Hospital, CHRU Lille","Department of Health, Lille 2 University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology, Claude Huriez Hospital, CHRU Lille","institution_ids":["https://openalex.org/I3018718406","https://openalex.org/I4210155195"]},{"raw_affiliation_string":"Department of Health, Lille 2 University","institution_ids":["https://openalex.org/I2279609970"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024945159","display_name":"Pauline Lepesant","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2279609970","display_name":"Universit\u00e9 de Lille","ror":"https://ror.org/02kzqn938","country_code":"FR","type":"education","lineage":["https://openalex.org/I2279609970"]},{"id":"https://openalex.org/I3018718406","display_name":"Centre Hospitalier Universitaire de Lille","ror":"https://ror.org/02ppyfa04","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3018718406"]},{"id":"https://openalex.org/I4210155195","display_name":"H\u00f4pital Claude Huriez","ror":"https://ror.org/05cpv3t46","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3018718406","https://openalex.org/I4210155195"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Pauline Lepesant","raw_affiliation_strings":["Department of Dermatology, Claude Huriez Hospital, CHRU Lille","Department of Health, Lille 2 University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology, Claude Huriez Hospital, CHRU Lille","institution_ids":["https://openalex.org/I3018718406","https://openalex.org/I4210155195"]},{"raw_affiliation_string":"Department of Health, Lille 2 University","institution_ids":["https://openalex.org/I2279609970"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083267352","display_name":"Eve Desmedt","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3018718406","display_name":"Centre Hospitalier Universitaire de Lille","ror":"https://ror.org/02ppyfa04","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3018718406"]},{"id":"https://openalex.org/I4210155195","display_name":"H\u00f4pital Claude Huriez","ror":"https://ror.org/05cpv3t46","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3018718406","https://openalex.org/I4210155195"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Eve Desmedt","raw_affiliation_strings":["Department of Dermatology, Claude Huriez Hospital, CHRU Lille"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology, Claude Huriez Hospital, CHRU Lille","institution_ids":["https://openalex.org/I3018718406","https://openalex.org/I4210155195"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062568098","display_name":"Carole Templier","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3018718406","display_name":"Centre Hospitalier Universitaire de Lille","ror":"https://ror.org/02ppyfa04","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3018718406"]},{"id":"https://openalex.org/I4210155195","display_name":"H\u00f4pital Claude Huriez","ror":"https://ror.org/05cpv3t46","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3018718406","https://openalex.org/I4210155195"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Carole Templier","raw_affiliation_strings":["Department of Dermatology, Claude Huriez Hospital, CHRU Lille"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology, Claude Huriez Hospital, CHRU Lille","institution_ids":["https://openalex.org/I3018718406","https://openalex.org/I4210155195"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091873689","display_name":"V\u00e9ronique Dziwniel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I7454413","display_name":"Centrale Lille Institut","ror":"https://ror.org/01x441g73","country_code":"FR","type":"education","lineage":["https://openalex.org/I7454413"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"V\u00e9ronique Dziwniel","raw_affiliation_strings":["Department of Modern Languages, Centrale Lille, Villeneuve d\u2019Ascq"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Modern Languages, Centrale Lille, Villeneuve d\u2019Ascq","institution_ids":["https://openalex.org/I7454413"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043652725","display_name":"Delphine Staumont-Sall\u00e9","orcid":"https://orcid.org/0000-0002-4780-4212","observed_orcids":["https://orcid.org/0000-0002-4780-4212"]},"institutions":[{"id":"https://openalex.org/I2279609970","display_name":"Universit\u00e9 de Lille","ror":"https://ror.org/02kzqn938","country_code":"FR","type":"education","lineage":["https://openalex.org/I2279609970"]},{"id":"https://openalex.org/I3018718406","display_name":"Centre Hospitalier Universitaire de Lille","ror":"https://ror.org/02ppyfa04","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3018718406"]},{"id":"https://openalex.org/I4210155195","display_name":"H\u00f4pital Claude Huriez","ror":"https://ror.org/05cpv3t46","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3018718406","https://openalex.org/I4210155195"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"Delphine Staumont-Sall\u00e9","raw_affiliation_strings":["Department of Dermatology, Claude Huriez Hospital, CHRU Lille","Department of Health, Lille 2 University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology, Claude Huriez Hospital, CHRU Lille","institution_ids":["https://openalex.org/I3018718406","https://openalex.org/I4210155195"]},{"raw_affiliation_string":"Department of Health, Lille 2 University","institution_ids":["https://openalex.org/I2279609970"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5077421764","display_name":"Laurent Mortier","orcid":"https://orcid.org/0000-0002-2644-1790","observed_orcids":["https://orcid.org/0000-0002-2644-1790"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I2279609970","display_name":"Universit\u00e9 de Lille","ror":"https://ror.org/02kzqn938","country_code":"FR","type":"education","lineage":["https://openalex.org/I2279609970"]},{"id":"https://openalex.org/I3018718406","display_name":"Centre Hospitalier Universitaire de Lille","ror":"https://ror.org/02ppyfa04","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3018718406"]},{"id":"https://openalex.org/I4210155195","display_name":"H\u00f4pital Claude Huriez","ror":"https://ror.org/05cpv3t46","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3018718406","https://openalex.org/I4210155195"]},{"id":"https://openalex.org/I4387152273","display_name":"OncoThAI","ror":"https://ror.org/04q29nn62","country_code":"FR","type":"facility","lineage":["https://openalex.org/I1294671590","https://openalex.org/I154526488","https://openalex.org/I2279609970","https://openalex.org/I2800921988","https://openalex.org/I3018718406","https://openalex.org/I4210131356","https://openalex.org/I4210141925","https://openalex.org/I4387152273","https://openalex.org/I4387152542"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"Laurent Mortier","raw_affiliation_strings":["Department of Dermatology, Claude Huriez Hospital, CHRU Lille","Department of Health, Lille 2 University","Image-Assisted Laser Therapies for Oncology: ONCO-THAI, Inserm U1189, Lille, France","fax: +33 320 445 916","to Laurent Mortier, MD, PhD, Department of Dermatology, Claude Huriez Hospital, Rue Michel Polonowski, 59037 Lille, France Tel: +33 320 444 193"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology, Claude Huriez Hospital, CHRU Lille","institution_ids":["https://openalex.org/I3018718406","https://openalex.org/I4210155195"]},{"raw_affiliation_string":"Department of Health, Lille 2 University","institution_ids":["https://openalex.org/I2279609970"]},{"raw_affiliation_string":"Image-Assisted Laser Therapies for Oncology: ONCO-THAI, Inserm U1189, Lille, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4387152273"]},{"raw_affiliation_string":"fax: +33 320 445 916","institution_ids":[]},{"raw_affiliation_string":"to Laurent Mortier, MD, PhD, Department of Dermatology, Claude Huriez Hospital, Rue Michel Polonowski, 59037 Lille, France Tel: +33 320 444 193","institution_ids":["https://openalex.org/I4210155195"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5043652725","https://openalex.org/A5077421764"],"corresponding_institution_ids":["https://openalex.org/I154526488","https://openalex.org/I2279609970","https://openalex.org/I3018718406","https://openalex.org/I4210155195","https://openalex.org/I4387152273"],"apc_list":null,"apc_paid":null,"fwci":0.9366,"has_fulltext":false,"cited_by_count":21,"citation_normalized_percentile":{"value":0.72142584,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"28","issue":"5","first_page":"451","last_page":"457"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.4480000138282776,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.4480000138282776,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12937","display_name":"Chemotherapy-related skin toxicity","score":0.3634999990463257,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.1031000018119812,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/metastatic-melanoma","display_name":"metastatic melanoma","score":0.9869999885559082},{"id":"https://openalex.org/keywords/combination-targeted-therapy","display_name":"combination targeted therapy","score":0.8220000267028809},{"id":"https://openalex.org/keywords/vemurafenib","display_name":"vemurafenib","score":0.9340000152587891},{"id":"https://openalex.org/keywords/cobimetinib","display_name":"cobimetinib","score":0.9909999966621399},{"id":"https://openalex.org/keywords/dabrafenib","display_name":"dabrafenib","score":1.0},{"id":"https://openalex.org/keywords/trametinib","display_name":"trametinib","score":0.9990000128746033},{"id":"https://openalex.org/keywords/skin-toxicity","display_name":"skin toxicity","score":0.550000011920929},{"id":"https://openalex.org/keywords/stevens-johnson-syndrome","display_name":"Stevens-Johnson syndrome","score":0.9490000009536743},{"id":"https://openalex.org/keywords/drug-reaction-with-eosinophilia-and-systemic-symptoms","display_name":"DRESS syndrome","score":0.9309999942779541},{"id":"https://openalex.org/keywords/immunotherapy","display_name":"immunotherapy","score":0.6790000200271606},{"id":"https://openalex.org/keywords/braf-inhibitors","display_name":"BRAF inhibitors","score":0.5239999890327454},{"id":"https://openalex.org/keywords/mek-inhibitors","display_name":"MEK inhibitors","score":0.9150000214576721},{"id":"https://openalex.org/keywords/first-line-treatment","display_name":"first-line therapy","score":0.5019999742507935},{"id":"https://openalex.org/keywords/second-line-treatment","display_name":"second-line therapy","score":0.9390000104904175}],"concepts":[{"id":"https://openalex.org/C2776131300","wikidata":"https://www.wikidata.org/wiki/Q423111","display_name":"Vemurafenib","level":4,"score":0.8949412107467651},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8742857575416565},{"id":"https://openalex.org/C2778830669","wikidata":"https://www.wikidata.org/wiki/Q3011604","display_name":"Dabrafenib","level":5,"score":0.7817894220352173},{"id":"https://openalex.org/C2778472372","wikidata":"https://www.wikidata.org/wiki/Q7833138","display_name":"Trametinib","level":4,"score":0.7788333296775818},{"id":"https://openalex.org/C2778570526","wikidata":"https://www.wikidata.org/wiki/Q653197","display_name":"Rash","level":2,"score":0.7156963348388672},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.663831353187561},{"id":"https://openalex.org/C2994587330","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Metastatic melanoma","level":3,"score":0.5711934566497803},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.5695162415504456},{"id":"https://openalex.org/C2781433595","wikidata":"https://www.wikidata.org/wiki/Q2459042","display_name":"Ipilimumab","level":4,"score":0.5476398468017578},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.5154100656509399},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4879152476787567},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4387563169002533},{"id":"https://openalex.org/C2993493390","wikidata":"https://www.wikidata.org/wiki/Q5453208","display_name":"First line","level":2,"score":0.4383660554885864},{"id":"https://openalex.org/C2781230642","wikidata":"https://www.wikidata.org/wiki/Q492646","display_name":"Targeted therapy","level":3,"score":0.41503962874412537},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.18477940559387207},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.10759323835372925},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.0},{"id":"https://openalex.org/C57074206","wikidata":"https://www.wikidata.org/wiki/Q14197552","display_name":"MAPK/ERK pathway","level":3,"score":0.0},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007167","descriptor_name":"Immunotherapy","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012878","descriptor_name":"Skin Neoplasms","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D012878","descriptor_name":"Skin Neoplasms","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D012878","descriptor_name":"Skin Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1097/cmr.0000000000000472","doi":"https://doi.org/10.1097/cmr.0000000000000472","is_oa":false,"landing_page_url":"https://doi.org/10.1097/cmr.0000000000000472","pdf_url":null,"source":{"id":"https://openalex.org/S3207524","display_name":"Melanoma Research","issn_l":"0960-8931","issn":["0960-8931","1473-5636"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Melanoma Research","raw_type":"journal-article"},{"id":"pmid:29985833","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/29985833","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Melanoma research","raw_type":"Journal Article"},{"id":"pmh:oai:HAL:hal-05353893v1","doi":null,"is_oa":false,"landing_page_url":"https://lilloa.hal.science/hal-05353893","pdf_url":null,"source":{"id":"https://openalex.org/S4306402512","display_name":"HAL","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4405252976","host_organization_name":"Centre pour la Communication Scientifique Directe","host_organization_lineage":["https://openalex.org/I4405252976"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Melanoma Research, 2018, Melanoma Research, 28 (5), pp.451-457. ⟨10.1097/CMR.0000000000000472⟩","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":18,"referenced_works":["https://openalex.org/W1840105071","https://openalex.org/W1903990865","https://openalex.org/W1974451438","https://openalex.org/W2004181803","https://openalex.org/W2011558284","https://openalex.org/W2018383416","https://openalex.org/W2030858378","https://openalex.org/W2048821807","https://openalex.org/W2052841051","https://openalex.org/W2098839625","https://openalex.org/W2127437403","https://openalex.org/W2146090786","https://openalex.org/W2150669821","https://openalex.org/W2160766792","https://openalex.org/W2164162782","https://openalex.org/W2173368453","https://openalex.org/W2491982852","https://openalex.org/W4319053765"],"related_works":["https://openalex.org/W2990517105","https://openalex.org/W2913619761","https://openalex.org/W4407605070","https://openalex.org/W3091844647","https://openalex.org/W3199488631","https://openalex.org/W4398241502","https://openalex.org/W4224245295","https://openalex.org/W4306750003","https://openalex.org/W2917321490","https://openalex.org/W2403405167"],"abstract_inverted_index":{"Targeted":[0],"therapy":[1],"combination":[2],"(TTC:":[3],"antiRAF+antiMEK)":[4],"is":[5],"known":[6],"to":[7,109],"improve":[8],"metastatic":[9],"melanoma":[10],"survival.":[11],"Few":[12],"severe":[13,58,87],"skin":[14,59,116],"toxicities":[15],"(grade":[16],"\u22653)":[17],"are":[18],"described":[19],"with":[20,90],"first-line":[21],"TTC":[22,41,97],"(17%":[23],"for":[24,28],"vemurafenib+cobimetinib":[25],"and":[26,45,83,92,119],"none":[27],"dabrafenib+trametinib)":[29],"in":[30,53,67,98,114],"a":[31],"phase":[32],"III":[33],"trial.":[34],"Among":[35],"our":[36],"42":[37],"patients":[38,65,99],"treated":[39,52,66],"by":[40,122],"between":[42],"January":[43],"2014":[44],"March":[46],"2017,":[47],"4.8%":[48],"(2/42)":[49],"of":[50,64,80,86],"those":[51],"the":[54,68,115],"first":[55],"line":[56,70],"presented":[57],"rash":[60,117],"versus":[61],"19%":[62],"(8/42)":[63],"second":[69],"after":[71],"previous":[72,106],"immunotherapy.":[73],"In":[74],"particular,":[75],"we":[76],"observed":[77],"one":[78],"case":[79],"Stevens-Johnson":[81],"syndrome":[82,95],"four":[84],"cases":[85],"drug":[88],"reaction":[89],"eosinophilia":[91],"systemic":[93],"symptoms":[94],"under":[96],"who":[100],"had":[101],"received":[102],"immunotherapy":[103,107],"previously.":[104],"Thus,":[105],"appears":[108],"play":[110],"an":[111],"important":[112],"role":[113],"onset":[118],"severity":[120],"induced":[121],"TTC.":[123]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2018-07-19T00:00:00"}